Paricalcitol Capsule, Liquid Filled
Product Images NDC 55111-665

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Paricalcitol (NDC 55111-665). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Paricalcitol Capsules, 1 mcg, liquid-filled oral capsules in a blister carton labeled by Dr. Reddy's Laboratories Limited. The label indicates a count of 30 capsules (3 blister cards of 10 unit doses each). It includes storage instructions to keep at 20°-25°C and protect from light. The label also mentions 2.5% v/v absolute alcohol as part of the formulation.*

FDA Label Image

Carton2 (Carton2)

Paricalcitol Capsules, 2 mcg, liquid-filled oral capsules by Dr. Reddy's Laboratories Limited. The label indicates the package contains 30 capsules (3 blister cards of 10 unit-dose capsules each). It includes storage instructions and dosing direction to consult the package insert. The label features the NDC 55111-664-81 and prominently displays the strength and alcohol content (2.5% w/w absolute alcohol).*

FDA Label Image

Carton3 (Carton3)

Packaging label for Paricalcitol Capsules, 4 mcg, a human prescription oral capsule product by Dr. Reddy's Laboratories Limited. The carton contains 30 capsules divided into 3 blister cards of 10 unit doses each. The label includes storage instructions and dosage reference, with branding and NDC 55111-665-81 visible.*

FDA Label Image

Container1 (Container1)

The label for Paricalcitol capsules, 1 mcg strength, liquid filled, oral dosage form. The label indicates a 30-capsule package distributed by Dr. Reddy's Laboratories Limited. It also notes 2.5% v/v absolute alcohol content in the formulation and general usage instructions to store at 20°C to 25°C.*

FDA Label Image

Container2 (Container2)

Paricalcitol Capsules, 2 mcg, liquid-filled oral capsules in a package containing 30 capsules. The label indicates 2.5% v/v absolute alcohol content. Manufactured by Dr. Reddy's Laboratories Limited, the package includes usage instructions, a barcode, and lot information.*

FDA Label Image

Container3 (Container3)

Paricalcitol Capsules 4 mcg packaging label by Dr. Reddy's Laboratories Limited. The label indicates 30 capsules in the package and states 2.5% w/v absolute alcohol content. It includes NDC 55111-665-30, administration instructions, storage conditions, and a barcode.*

FDA Label Image

Figure1 (Figure1)

A line graph comparing iPTH levels (pg/mL) over 23 weeks between Paricalcitol and Placebo groups. The x-axis represents weeks, and the y-axis shows iPTH concentration with values from 0 to 400 pg/mL. Paricalcitol group shows a declining trend, while Placebo remains relatively stable.*

FDA Label Image

Figure2 (Figure2)

A line chart showing the change in intact parathyroid hormone (iPTH) levels over 12 weeks, comparing Paricalcitol treatment (solid line) to placebo (dashed line). The vertical axis represents iPTH levels in pg/mL, and the horizontal axis indicates weeks from 0 to 12. Error bars are included for each data point.*

FDA Label Image

Structure (Structure)

Chemical structure of Paricalcitol, showing its molecular framework with hydroxyl groups and steroid ring system as characteristic features.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.